News
2h
InvestorsHub on MSNBristol-Myers Squibb Shares Climb as Growth Portfolio Fuels Strong Q2 Results
Bristol-Myers Squibb (NYSE:BMY) posted second-quarter earnings that surpassed analyst expectations, largely thanks to robust ...
Investing.com -- Bristol-Myers Squibb reported second-quarter earnings that exceeded analyst expectations, driven by strong ...
The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...
One relatively safe bet about how Pfizer's lineup will look different five years from now is that the company will be a ...
Editas' share price has struggled due to clinical setbacks, but recent focus on in-vivo gene editing offers renewed hope and ...
Does BioNTech SE Sponsored ADR (BNTX) have what it takes to be a top stock pick for momentum investors? Let's find out.
HHS Secretary RFK Jr. faces a probe launched by Democratic Senators over his decision to dismantle a key CDC vaccine advisory ...
Secretary Robert F. Kennedy Jr. is pledging a major overhaul of the National Vaccine Injury Compensation Program (VICP), ...
Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") announced today that the European Medicines Agency's (EMA) Committee for ...
New York drugmaker Pfizer and Mainz, Germany, immunotherapy company BioNTech said the European Commission, which generally follows CHMP's advice, will now review the recommendation, with a final ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results